ReviewMarine drugs2024
Marine Invasive Algae's Bioactive Ingredients as a Sustainable Pathway in Cosmetics: The Azores Islands as a Case Study.
Review in Marine drugs, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Solvent-Dependent Metabolomic Profiles and Antioxidant Properties of the Invasive SeaweedPharmaceuticals (Basel, Switzerland) · 2026Article
- Review
- Enzymes from mollusk-associated bacteria in Ambon waters of Wallacea: Prospective cosmetic applications.Open veterinary journal · 2026Article
- Overview of Primary and Secondary Metabolites ofMarine drugs · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Marine invasive species pose significant ecological, economic, and social challenges, disrupting native ecosystems, outcompeting local species and altering biodiversity. The spread of these species is largely driven by global trade, shipping, and climate change, which allow non-native species to establish themselves in new environments. Current management strategies, including early detection, rapid response, and biosecurity measures, have had some success, but the complexity and scale of the problem require continuous monitoring. This review explores the possibility of using some marine invasive species as skincare ingredients and explores the Azorean islands as a case study for the valorization of biomass. Additionally, this review addresses legislative barriers that delay the development of sustainable cosmetic markets from invasive species, highlighting the regulatory landscape as a critical area. It concludes that marine invasive species present a regional and global problem that requires regional and global solutions. Such solutions strongly need to address environmental impacts and net socioeconomic benefits, but such solutions must also consider all regional differences, technical capacities and financial resources available. Thus, as a future perspective, strategies should emphasize the need for international collaboration and the development of more effective policies to prevent the spread of invasive species. There is still much work to be completed. By working together, the biodiversity for future generations will be better monitored and explored.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.